**Core Concept**
The management of bronchial asthma involves various pharmacological agents targeting different aspects of the disease's pathophysiology, including inflammation, bronchoconstriction, and airway hyperresponsiveness. **Bronchodilators**, **anti-inflammatory agents**, and **immunomodulators** are commonly used.

**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general approach to asthma management. **Inhaled corticosteroids** are the cornerstone of asthma treatment due to their potent **anti-inflammatory** effects. **Beta-2 agonists** act as **bronchodilators** by stimulating **beta-2 adrenergic receptors** in the airway smooth muscle, leading to relaxation and bronchodilation.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option provided, it's challenging to give a precise reason. However, if it were a commonly used asthma medication, it would be incorrect to say it's not used in asthma.
**Option B:** Similarly, without specifics, if this option is a recognized treatment, it would be incorrect to exclude it.
**Option C:** If this option represents a medication not typically used for asthma, such as a medication for a different condition, it could be the correct answer due to its irrelevance to asthma management.
**Option D:** Again, lacking specifics, if this is a standard asthma treatment, it would be incorrect to say it's not used.

**Clinical Pearl / High-Yield Fact**
A key point in asthma management is the stepwise approach for controlling symptoms and preventing exacerbations, often involving the combination of **inhaled corticosteroids** and **long-acting beta-2 agonists** for moderate to severe asthma.

**Correct Answer:**